Natural Capsules Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹58.45 crore, reflecting a quarter-on-quarter *(QoQ) increase of 54.83 per cent from ₹37.75 crore. This corresponds to a year-on-year *(YoY) growth of 29.98 per cent.
Operating Profit
Operating Profit stands at ₹1.33 crore, reflecting a quarter-on-quarter *(QoQ) increase of 157.33 per cent from ₹-2.32 crore. This corresponds to a year-on-year *(YoY) decline of 69.63 per cent.
PBDT
PBDT stands at ₹-0.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 83.09 per cent from ₹-4.73 crore. This corresponds to a year-on-year *(YoY) decline of 126.23 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-5.08 crore, reflecting a quarter-on-quarter *(QoQ) increase of 44.11 per cent from ₹-9.09 crore. This corresponds to a year-on-year *(YoY) decline of 670.79 per cent.
Net Profit
Net Profit stands at ₹-4.98 crore, reflecting a quarter-on-quarter *(QoQ) increase of 30.06 per cent from ₹-7.12 crore. This represents a 1,057.69 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Natural Capsules Ltd Earnings
- YOY
- QOQ
Natural Capsules Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Natural Capsules Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Natural Capsules Ltd Financial Reports
Natural Capsules Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Natural Capsules | -1.34% | -4.12% | -3.73% | -7.11% | -15.05% | -33.15% |
| Parnax Lab | 1.05% | -1.84% | 3.81% | -14.09% | 12.78% | 11.65% |
| Panch.Organics | 1.71% | 0.76% | 1.15% | 3.25% | 13.17% | -31.13% |
| Speciality Medi. | -6.36% | -2.75% | -10.43% | -44.23% | 39.08% | 39.08% |
| Kimia Bioscien. | 1.00% | -2.46% | -2.16% | -9.69% | 4.02% | -43.64% |
| Auro Labs. | 0.64% | -1.46% | -8.58% | -4.52% | 6.17% | -13.64% |
| Bal Pharma | 0.45% | -0.80% | 10.35% | 17.07% | 24.80% | -8.84% |
Company Info
Company Information
Chairman & Independent Directo : T Y Prabhu
Executive Director & MD : Sunil L Mundra
E D & Wholetime Director : Satyanarayan Mundra
E D & Wholetime Director : Laxminarayan Mundra
Non Executive Director : Sushil Kumar Mundra
Independent Non Exe. Director : Pramod Kasat
Independent Non Exe. Director : Shirish Gundopant Belapure
Non Executive Director : Jyothi Mundra
Company Sec. & Compli. Officer : Pranjal Deshmukh